Chronic pain is a complex and often debilitating condition that affects millions of people worldwide. Understanding the neurophysiological mechanisms underlying chronic pain is crucial for ...

In contrast to acute pain, which has important warning and protection functions, chronic pain is a maladaptive mechanism that continues long after recovery from an injury or disease. Treatment of ...

The encouraging result comes just days after the US FDA approved Vertex Pharma's non-opioid painkiller Journavx (suzetrigine) ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

New research from McGill University reveals that listening to music at your own rhythm can significantly reduce pain.

Over the past couple of decades, interest in the administration of sub-anesthetic doses of ketamine, that mostly avoid side effects, for relief of acute and chronic pain has grown steadily. The ...

The Phase IIa results continue a surge of momentum in a treatment space that last week saw the approval of Vertex’s Journavx ...

Scientists at the Centre for Neuroscience (CNS), Indian Institute of Science (IISc), Bengaluru, have uncovered how neurons in different brain regions collaborate to control chronic pain in mice ...

And there is no national center for the study of chronic pain. But researchers are finally beginning to understand the underlying mechanisms of pain — and how to treat it. Some people are more ...

A common genetic pathway may account for increased risk for atherosclerotic disease in patients with chronic widespread musculoskeletal pain.

A dysfunctional signaling pathway in the hippocampus has been linked to chronic pain-related memory impairment in mice.

Indian Institute of Science scientists have discovered how specific brain regions collaborate to manage chronic pain in mice, particularly from chemotherapy. Key findings show the lateral ...